ITGAM and neoplasm: At the same time, vascular normalizing doses of antiangiogenic treatment reprogram the immunosuppressive tumor microenvironment5, 19, the inhibition effect of 100 mg/kg SH on CD11b+Gr-1+ MDSCs recruitment is greatly due to the improved tumor perfusion.